Published December 2010
| public
Conference Paper
Polymer nanoparticle-based cancer therapeutics: from concept to clinic
- Creators
-
Davis, M. E.
Chicago
An error occurred while generating the citation.
Abstract
Nanoparticle-based therapeutics contg. either small mol. anti-cancer agents (IT-101; entered Phase II) or siRNA (CALAA-01; in Phase I) are described. The key component in each nanoparticle is a cyclodextrin-contg. polymer that endows it with multifunctional behavior. Relationships between nanoparticle design and function in animal models are illustrated. Results from clin. trials are presented so show how nanoparticle-based therapeutics can provide interesting behavior in humans.
Additional Information
© 2012 American Chemical Society.Additional details
- Eprint ID
- 33240
- Resolver ID
- CaltechAUTHORS:20120815-152834973
- Created
-
2012-08-15Created from EPrint's datestamp field
- Updated
-
2020-03-09Created from EPrint's last_modified field